Clinical Trials Directory

Trials / Completed

CompletedNCT00725426

Effect of Rifampin on Bosutinib When Both Are Given to Healthy People

A Study to Examine the Potential Effect of Rifampin on the Pharmacokinetics of Bosutinib When Administered Concomitantly to Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Study to examine whether rifampin has an effect on the pharmacokinetics of bosutinib.

Conditions

Interventions

TypeNameDescription
DRUGBosutinib

Timeline

Start date
2008-07-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2008-07-30
Last updated
2009-04-27

Source: ClinicalTrials.gov record NCT00725426. Inclusion in this directory is not an endorsement.

Effect of Rifampin on Bosutinib When Both Are Given to Healthy People (NCT00725426) · Clinical Trials Directory